Scancell Holdings plc (SCNLF)
OTCMKTS · Delayed Price · Currency is USD
0.1900
0.00 (0.00%)
At close: Jan 30, 2026
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of $176.71 million as of February 12, 2026. Its market cap has increased by 47.23% in one year.
Market Cap
176.71M
Enterprise Value
187.07M
Revenue
6.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 5.18M to 176.71M, an increase of 3,309.26%. That is a compound annual growth rate of 23.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 176.71M | 27.79% |
| Dec 31, 2025 | 138.28M | 0.02% |
| Dec 31, 2024 | 138.25M | 26.11% |
| Dec 29, 2023 | 109.63M | -54.91% |
| Dec 30, 2022 | 243.11M | 10.12% |
| Dec 31, 2021 | 220.77M | 41.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 411.40M |
| CytoDyn | 305.90M |
| Silence Therapeutics | 204.52M |
| HST Global | 139.70M |
| Vaxart | 137.92M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 72.43M |
| VitaSpring Biomedical | 51.78M |